SELLAS Life Sciences Group, Inc. (SLS) — Net Income

Annual figures by fiscal year, from SEC filings.

2010: -$11.99M2011: -$11.48M2012: -$34.97M2013: -$76.68M2014: -$36.61M2015: -$63.90M2016: -$17.68M2017: -$23.75M2018: -$27.67M2019: -$19.29M2020: -$16.76M2021: -$20.70M2022: -$41.30M2023: -$37.34M2024: -$30.88M2025: -$26.86M-$26.86M
2010Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$26.86M+13.0%
2024-$30.88M+17.3%
2023-$37.34M+9.6%
2022-$41.30M-99.5%
2021-$20.70M-23.5%
2020-$16.76M+13.1%
2019-$19.29M+30.3%
2018-$27.67M-16.5%
2017-$23.75M-34.3%
2016-$17.68M+72.3%
2015-$63.90M-74.6%
2014-$36.61M+52.3%
2013-$76.68M-119.3%
2012-$34.97M-204.5%
2011-$11.48M+4.2%
2010-$11.99M